Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India
· Delayed Price · Currency is INR 719.90
-3.65 (-0.50%)
Apr 30, 2025, 11:30 AM IST
Tatva Chintan Pharma Chem Revenue
Tatva Chintan Pharma Chem had revenue of 858.96M INR in the quarter ending December 31, 2024, with 2.01% growth. This brings the company's revenue in the last twelve months to 3.73B, down -11.11% year-over-year. In the fiscal year ending March 31, 2024, Tatva Chintan Pharma Chem had annual revenue of 3.94B, down -7.11%.
Revenue (ttm)
3.73B
Revenue Growth
-11.11%
P/S Ratio
4.54
Revenue / Employee
5.42M
Employees
689
Market Cap
16.93B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UltraTech Cement | 759.55B |
| Asian Paints | 342.20B |
| Grasim Industries | 1,399.44B |
| Vedanta | 1,462.52B |
| Pidilite Industries | 129.01B |
| Solar Industries India | 69.84B |
| Shree Cement | 192.69B |
| Jindal Steel & Power | 500.69B |